Read more
The first single-topic annual conference on hepatology in Japan was held in November 2002 to discuss therapies for viral hepatitis and the prevention of hepatocellular carcinoma (HCC). Bringing together researchers and clinicians from North America, Europe, Japan, and other parts of Asia, the conference included symposia on the hepatitis C replicon system, new antivirals that lower or prevent the incidence of HCC, and transplantation in cases of hepatitis B and C, as well as new treatment modalities for viral hepatitis and preventative measures for HCC. With the rising number of HCC cases worldwide, this collection of papers presented at the conference provides a valuable, up-to-date resource and reference for all professionals involved in the treatment and prevention of viral hepatitis and hepatocellular carcinoma.
List of contents
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma.- Lamivudine Therapy for Hepatitis B.- New Anti-virals: HBV.- Therapy for Hepatitis B and Prevention of HCC.- HCV Replicon System.- New Anti-virals: HCV.- Interferon Therapy for Hepatitis C.- Therapy for Hepatitis C and Prevention of HCC.- Chemoprevention and Therapy for HCC.- Transplantation for HBV and HCV.
About the author
Kiwamu OkitaProfessor, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
Summary
The liver has an important role in nutritional homeostasis, and it is well known that liver diseases can lead to abnormalities in the nutrient metabolism and to subsequent malnutrition. Because malnutrition is particularly prevalent in patients with liver cirrhosis, proper nutritional assessment and support for cirrhotic patients is essential. This collection of research and clinical findings on nonalcoholic steatohepatitis (NASH) and nutritional therapy contains significant new findings in several fields. As NASH frequently causes liver cirrhosis, the nutritional aspects of its treatment are discussed. Other areas covered include nonalcoholic fatty liver, the role of leptin in the pathogenesis of NASH, restricted diets and exercise therapy, mammalian targets of the peptide rapamycin, and genetic factors influencing the development of NASH. This book is intended to be of particular relevance to researchers and those practicing in the field.
